| HGNC Family | Non-coding RNAs |
| Name | microRNA 409 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‐409, particularly the –3p strand, has emerged as a multifaceted regulator in human pathophysiology. In several solid tumors—including gastric, colorectal, bladder, endometrial, glioma, and breast cancers—miR‐409–3p is frequently downregulated. Its restoration suppresses cell proliferation, migration, invasion, metastasis, and autophagy by directly targeting a variety of oncogenic transcripts such as radixin, PHF10, angiogenin, c‐Met, GAB1, Beclin‐1, Akt1, SMAD2, and HMGN5. These tumor‐suppressive activities contribute to reduced metastatic potential and improved chemosensitivity in preclinical models."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "14"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn contrast, within the tumor microenvironment—particularly in prostate cancer—both miR‐409–3p and –5p are upregulated in cancer‐associated stromal fibroblasts. This upregulation reprograms normal fibroblasts into a cancer‐associated phenotype and promotes epithelial–mesenchymal transition and tumorigenesis through repression of tumor‐suppressor genes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMiR‐409 is also embedded within complex noncoding RNA regulatory networks. In certain cancers, circular RNAs act as molecular sponges for miR‐409–3p, thereby releasing its target oncogenes. For example, in cervical cancer and osteosarcoma, sponging of miR‐409–3p by circFAT1 or circATRNL1 contributes to enhanced migration, invasion, and metabolic reprogramming. Moreover, miR‐409–3p forms part of biomarker panels in nasopharyngeal carcinoma for cancer diagnosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "19"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncology, aberrant miR‐409–3p expression is implicated in nonmalignant conditions. In primary immune thrombocytopenia, reduced miR‐409–3p levels correlate with increased interferon‐γ expression, suggesting a role in immune dysregulation. Similarly, in gestational diabetes mellitus, altered circulating miR‐409–3p levels in plasma and extracellular vesicles are associated with fasting glucose levels and gestational age, pointing to its potential as a metabolic biomarker."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional studies in liver and lung cancers further underscore the versatility of miR‐409. In liver cancer, miR‐409 is linked to regulation of the Jak–Stat pathway, while in non‐small cell lung carcinoma, it is modulated through competing endogenous RNA networks that impact oncogene expression. These findings highlight miR‐409’s promise as a therapeutic target across diverse malignancies."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nNotably, strand‐specific functions have been observed in breast cancer. While miR‐409–3p generally exhibits tumor‐suppressive properties by targeting molecules such as Akt1 and ZEB1 to inhibit metastasis, the –5p strand is reported to be aberrantly upregulated in breast tumors. Downregulation of miR‐409–5p results in decreased proliferation, migration, and xenograft growth, an effect mediated at least in part by derepression of Ras suppressor protein 1. These divergent roles underscore the complexity of miR‐409 biogenesis and function in cancer."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}, {"type": "fg_f", "ref": "11"}, {"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "B Zheng, L Liang, S Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.581"}], "href": "https://doi.org/10.1038/onc.2011.581"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22179828"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22179828"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Chenglong Li, Hui Nie, Ming Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2012.02.030"}], "href": "https://doi.org/10.1016/j.canlet.2012.02.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22388101"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22388101"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Chunhua Weng, Haojie Dong, Guangdi Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2012.04.010"}], "href": "https://doi.org/10.1016/j.canlet.2012.04.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22531314"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22531314"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xin Xu, Hong Chen, Yiwei Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cells (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10059-013-0044-7"}], "href": "https://doi.org/10.1007/s10059-013-0044-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23820886"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23820886"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Rongpan Bai, Chunhua Weng, Haojie Dong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.29607"}], "href": "https://doi.org/10.1002/ijc.29607"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25991585"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25991585"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Mulin Liu, Aman Xu, Xiao Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Transl Med (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12967-015-0533-x"}], "href": "https://doi.org/10.1186/s12967-015-0533-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26084278"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26084278"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Guoqiang Zhang, Zengyan Liu, Hao Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-409-3p suppresses breast cancer cell growth and invasion by targeting Akt1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2015.11.099"}], "href": "https://doi.org/10.1016/j.bbrc.2015.11.099"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26631969"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26631969"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Shifan Tan, Huijuan Shi, Mingchen Ba, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-409-3p sensitizes colon cancer cells to oxaliplatin by inhibiting Beclin-1-mediated autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2016.2492"}], "href": "https://doi.org/10.3892/ijmm.2016.2492"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26935807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26935807"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Shifeng Wu, Xinjie Du, Manwu Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-409-3p inhibits osteosarcoma cell migration and invasion by targeting catenin-δ1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2016.03.021"}], "href": "https://doi.org/10.1016/j.gene.2016.03.021"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26992637"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26992637"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Susanna Khalil, Enrica Fabbri, Alessandra Santangelo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA array screening reveals cooperative MGMT-regulation between miR-181d-5p and miR-409-3p in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.8618"}], "href": "https://doi.org/10.18632/oncotarget.8618"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27057640"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27057640"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Zhenhai Ma, Yang Li, Jingchao Xu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "IUBMB Life (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/iub.1494"}], "href": "https://doi.org/10.1002/iub.1494"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27079864"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27079864"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "G-H Cao, X-L Sun, F Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Low expression of miR-409-3p is a prognostic marker for breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2016)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27735035"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27735035"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Yidong Cao, Liang Zhang, Minghao Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-409-3p Represses Glioma Cell Invasion and Proliferation by Targeting High-Mobility Group Nucleosome-Binding Domain 5."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3727/096504017X14836170586829"}], "href": "https://doi.org/10.3727/096504017X14836170586829"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28109076"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28109076"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Chunhua Zhang, Bo Wang, Ling Wu "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA‑409 may function as a tumor suppressor in endometrial carcinoma cells by targeting Smad2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Med Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/mmr.2018.9642"}], "href": "https://doi.org/10.3892/mmr.2018.9642"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30431090"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30431090"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Sajni Josson, Murali Gururajan, Peizhen Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-14-0305"}], "href": "https://doi.org/10.1158/1078-0432.CCR-14-0305"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24963047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24963047"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "S Josson, M Gururajan, S Y Sung, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.212"}], "href": "https://doi.org/10.1038/onc.2014.212"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25065597"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25065597"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Li Jiang, Yong Zhang, Bo Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.14883"}], "href": "https://doi.org/10.1111/cas.14883"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33728743"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33728743"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Maria Goldberg, Md Rezaul Islam, Cemil Kerimoglu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exercise as a model to identify microRNAs linked to human cognition: a role for microRNA-409 and microRNA-501."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Transl Psychiatry (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41398-021-01627-w"}], "href": "https://doi.org/10.1038/s41398-021-01627-w"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34625536"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34625536"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Quanbin Zhang, Lina Wang, Lili Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Novel circular RNA circATRNL1 accelerates the osteosarcoma aerobic glycolysis through targeting miR-409-3p/LDHA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.1985343"}], "href": "https://doi.org/10.1080/21655979.2021.1985343"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34635009"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34635009"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Huiyuan Li, Haifeng Zhao, Feng Xue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced expression of MIR409-3p in primary immune thrombocytopenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Haematol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bjh.12213"}], "href": "https://doi.org/10.1111/bjh.12213"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23360331"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23360331"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Tiziana Filardi, Giuseppina Catanzaro, Giuseppina Emanuela Grieco, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and Validation of miR-222-3p and miR-409-3p as Plasma Biomarkers in Gestational Diabetes Mellitus Sharing Validated Target Genes Involved in Metabolic Homeostasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms23084276"}], "href": "https://doi.org/10.3390/ijms23084276"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35457094"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35457094"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "C-S Zhang, Y Lin, F-B Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-409 down-regulates Jak-Stat pathway to inhibit progression of liver cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201901_16758"}], "href": "https://doi.org/10.26355/eurrev_201901_16758"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30657556"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30657556"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Lingling Wang, Lei Wu, Jinfeng Pang "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA PSMA3‑AS1 functions as a microRNA‑409‑3p sponge to promote the progression of non‑small cell lung carcinoma by targeting spindlin 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2020.7693"}], "href": "https://doi.org/10.3892/or.2020.7693"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32945481"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32945481"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Hong Yu, Hua Xing, Wei Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317701647"}], "href": "https://doi.org/10.1177/1010428317701647"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28459205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28459205"}]}]}]}
|
| Synonyms | HSA-MIR-409, MIRN409, MIR-409 |
| NCBI Gene ID | 574413 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR409 has 313 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 13 datasets.
Click the + buttons to view associations for MIR409 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR409 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR409 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR409 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR409 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR409 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR409 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR409 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR409 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR409 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR409 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR409 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR409 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR409 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |